Millennium Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,084,843
Closed -$2.59M 5975
2025
Q4
$2.59M Sell
1,084,843
-504,693
-32% -$1.38M ﹤0.01% 3717
2025
Q3
$4.53M Buy
1,589,536
+1,528,710
+2,513% +$5.23M ﹤0.01% 3249
2025
Q2
$229K Sell
60,826
-437,255
-88% -$1.72M ﹤0.01% 5305
2025
Q1
$2.26M Sell
498,081
-1,487,611
-75% -$7.87M ﹤0.01% 3669
2024
Q4
$14M Buy
1,985,692
+258,853
+15% +$2.06M 0.01% 1839
2024
Q3
$14.1M Sell
1,726,839
-686,441
-28% -$4.96M 0.01% 1874
2024
Q2
$15.4M Buy
2,413,280
+1,184,131
+96% +$7.6M 0.01% 1708
2024
Q1
$9.26M Buy
1,229,149
+202,261
+20% +$1.85M ﹤0.01% 2268
2023
Q4
$9.51M Buy
1,026,888
+776,968
+311% +$6.35M ﹤0.01% 2240
2023
Q3
$2.53M Sell
249,920
-166,579
-40% -$1.99M ﹤0.01% 3343
2023
Q2
$5.21M Sell
416,499
-1,178,776
-74% -$14M ﹤0.01% 2642
2023
Q1
$18.6M Sell
1,595,275
-202,599
-11% -$2.58M 0.01% 1381
2022
Q4
$19.1M Sell
1,797,874
-142,985
-7% -$1.38M 0.01% 1486
2022
Q3
$18.8M Buy
1,940,859
+1,323,571
+214% +$17.5M 0.01% 1400
2022
Q2
$8.95M Buy
617,288
+153,182
+33% +$2.61M 0.01% 2178
2022
Q1
$12.1M Buy
464,106
+131,139
+39% +$3.72M 0.01% 1927
2021
Q4
$13.2M Buy
332,967
+197,509
+146% +$9M 0.01% 1847
2021
Q3
$6.77M Sell
135,458
-59,628
-31% -$3.25M ﹤0.01% 2533
2021
Q2
$10.8M Sell
195,086
-73,790
-27% -$3.93M 0.01% 1807
2021
Q1
$12.6M Buy
268,876
+40,966
+18% +$1.98M 0.01% 1539
2020
Q4
$9.92M Buy
+227,910
New +$8.41M 0.01% 1744
2020
Q3
Sell
-180,875
Closed -$5.28M 4599
2020
Q2
$5.28M Buy
180,875
+147,867
+448% +$4.09M 0.01% 1716
2020
Q1
$863K Buy
+33,008
New +$1.01M ﹤0.01% 2558
2019
Q4
Sell
-23,261
Closed -$735K 4378
2019
Q3
$735K Buy
+23,261
New +$916K ﹤0.01% 3036

Other funds holding HCAT

Millennium Management's HCAT Position: Q1 2026 in Review

Millennium Management sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 1,084,843 shares — an estimated $2.59M sold.

Millennium Management first reported a position in HCAT in Q3 2019 and held it in 24 quarters. The position peaked at $19.1M in Q4 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Millennium Management reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 1,084,843 Health Catalyst shares in Q1 2026, an estimated $2.59M.
  • Millennium Management first reported a position in Health Catalyst in Q3 2019 and held it in 24 quarters.
  • Millennium Management's Health Catalyst position peaked at $19.1M in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.